Lonza
Company Snapshot
Company Overview
Lonza is a biotechnology company that helps pharmaceutical, biotech and nutrition companies bring their treatments to the market. The company operates in four segments: Small Molecules, Biologics, Cell and gene, and Capsules and health Ingredients.
The Cell & Gene division includes three business areas: Cell & Gene Technologies, Personalized Medicine, and Bioscience. Cell & Gene Technologies (CGT) is focused on providing an integrated range of CDMO services that span the complete value chain of cell and gene therapy modalities (allogeneic and autologous therapies and viral vectors). CDMO services include 2D/3D cell culture and the latest exosome development and manufacturing technologies.
Financial Highlights (FY 2024)
This information is available for BCC Research members only.
Company's Business Segments
- Biologics : Mammalian, Microbial, Bioconjugates, mRNA, Drug product services
- Small Molecules : Drug substance, Particle engineering, Drug product development and manufacturing
- Cell and Gene : Development and manufacturing services, Products, Solutions, Testing and automation platforms
- Capsules and Health Ingredients : Wide range of animal-based vegetarian and clean label Capsugel capsule, Pre-clinical and clinical solutions, Specialized delivery applications
Applications/End User Industries
- Pharmaceuticals
- Nutraceuticals
- Life Sciences
- Biotechnology
- Manufacturing Services
